Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.28 USD | -1.41% | -6.39% | -9.35% |
Apr. 30 | Harmony Biosciences Acquires Epygenix Therapeutics; Shares Rise | MT |
Apr. 30 | Transcript : Harmony Biosciences Holdings, Inc., Q1 2024 Earnings Call, Apr 30, 2024 |
Financials (USD)
Sales 2024 * | 712M | Sales 2025 * | 842M | Capitalization | 1.69B |
---|---|---|---|---|---|
Net income 2024 * | 141M | Net income 2025 * | 232M | EV / Sales 2024 * | 1.96 x |
Net cash position 2024 * | 292M | Net cash position 2025 * | 524M | EV / Sales 2025 * | 1.38 x |
P/E ratio 2024 * |
12.8
x | P/E ratio 2025 * |
7.73
x | Employees | 246 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 58.66% |
Latest transcript on Harmony Biosciences Holdings, Inc.
1 day | -1.41% | ||
1 week | -7.63% | ||
Current month | -5.27% | ||
1 month | -0.81% | ||
3 months | -16.49% | ||
6 months | +16.19% | ||
Current year | -9.35% |
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Dayno
CEO | Chief Executive Officer | 66 | 17-10-31 |
Director of Finance/CFO | 54 | 21-03-28 | |
Kumar Budur
CTO | Chief Tech/Sci/R&D Officer | 53 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Aronin
FOU | Founder | 56 | 17-07-24 |
R. Graf
BRD | Director/Board Member | 59 | 20-11-10 |
Andreas Wicki
BRD | Director/Board Member | 64 | 17-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.52% | 14 M€ | -2.11% | ||
0.35% | 28 M€ | -0.39% | ||
0.31% | 25 M€ | -1.18% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 29.28 | -1.41% | 340,312 |
24-05-15 | 29.7 | -0.54% | 293,285 |
24-05-14 | 29.86 | -1.19% | 297,236 |
24-05-13 | 30.22 | +0.27% | 270,867 |
24-05-10 | 30.14 | -3.64% | 250,707 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.35% | 1.69B | |
+32.36% | 709B | |
+30.77% | 595B | |
-1.60% | 367B | |
+20.07% | 334B | |
+6.04% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+9.27% | 171B |
- Stock Market
- Equities
- HRMY Stock